Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Fidelis Pharmaceuticals
AddedFeb 15, 2024
UpdatedJun 18, 2026
Fidelis Pharmaceuticals

Fidelis Pharmaceuticals

Series A

Fidelis Pharmaceuticals: US-based provider of unique veterinary formulations, serving global needs.

HQ
North Brunswick, NJ, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Fidelis Pharmaceuticals is a U.S.-based company specializing in the acquisition, development, and marketing of unique pharmaceutical formulations tailored to specialized veterinary needs. Headquartered in North Brunswick, New Jersey, Fidelis focuses on providing innovative drug delivery technology and long-lasting pain management solutions for animals. The company operates globally from the Northeast pharmaceutical corridor, aiming to address critical gaps in veterinary medicine.

Fidelis Pharmaceuticals has established itself as a leader in veterinary pain management through its extensive pipeline of innovative products. The company's expertise in drug delivery technology has enabled it to develop effective and long-lasting formulations that significantly improve animal health and welfare. Fidelis continues to make a substantial impact in the veterinary pharmaceutical industry, driven by its commitment to addressing specialized veterinary needs worldwide.

Fidelis Pharmaceuticals - Similar Companies

Wilmington Pharmaceuticals logo

Wilmington Pharmaceuticals

Elite Pharmaceuticals logo

Elite Pharmaceuticals

elitepharma.com

US Specialty Formulations logo

US Specialty Formulations

Companion Pharma logo

Companion Pharma

WayPath Pharma logo

WayPath Pharma

waypathpharma.com

Pinpoint Pharma logo

Pinpoint Pharma

pinpointpharma.co

Solace Pharmaceuticals logo

Solace Pharmaceuticals

Auxilius Pharma logo

Auxilius Pharma

auxiliuspharma.com

Reiley Pharmaceuticals logo

Reiley Pharmaceuticals

Amerigen Pharmaceuticals logo

Amerigen Pharmaceuticals

amerigenpharma.com

6S Pharma logo

6S Pharma

6spharma.com

Trilogic Pharma logo

Trilogic Pharma

trilogicpharma.com

Concours Pharmaceuticals logo

Concours Pharmaceuticals

PleoPharma logo

PleoPharma

pleopharma.com

NovaDel Pharma logo

NovaDel Pharma

Fidelis Pharmaceuticals - Quick Facts

Who are Fidelis Pharmaceuticals' competitors?

Companies similar to Fidelis Pharmaceuticals include Wilmington Pharmaceuticals, Elite Pharmaceuticals, US Specialty Formulations and Companion Pharma.

When was Fidelis Pharmaceuticals founded?

Fidelis Pharmaceuticals was founded in 2016.

Where is Fidelis Pharmaceuticals' headquarters located?

Fidelis Pharmaceuticals' headquarters is located in North Brunswick, NJ, US.

When was Fidelis Pharmaceuticals' last funding round?

Fidelis Pharmaceuticals' most recent funding round was for $5.1M (USD) in July 2021.

How much has Fidelis Pharmaceuticals raised to-date?

As of Jul 21, 2021, Fidelis Pharmaceuticals has raised a total of $5.1M (USD).

How many employees does Fidelis Pharmaceuticals have?

Fidelis Pharmaceuticals has 6 employees as of Feb 5, 2024.

Fidelis Pharmaceuticals - Classification

Ownership
  • Private
Technology
  • Data
Geographic Exposure
  • Global
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
  • Veterinary
Tags
  • Biotech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
Show 14 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 7300Business Services
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research